Dressen S, Schneider J, Doenhardt M, Diffloth N, Tenenbaum T, Schneider D
Infection. 2025; .
PMID: 40064762
DOI: 10.1007/s15010-025-02494-z.
Waldeck F, Kramer T, Boutin S, Matten J, Kramer J, Rupp J
BMC Infect Dis. 2025; 25(1):318.
PMID: 40050786
PMC: 11884198.
DOI: 10.1186/s12879-025-10657-4.
Leber A, Embry T, Everhart K, Taveras J, Oyeniran S, Wang H
Emerg Infect Dis. 2025; 31(3):555-558.
PMID: 40023809
PMC: 11878328.
DOI: 10.3201/eid3103.241570.
Smit P, Eggink D, Paltansing S, Hooiveld M, van Gageldonk-Lafeber A, Dunk D
Sci Rep. 2025; 15(1):6985.
PMID: 40011487
PMC: 11865550.
DOI: 10.1038/s41598-025-88990-6.
Ma J, Tian T, Zeng N, Gu Y, Ren X, Jin Z
AMB Express. 2025; 15(1):25.
PMID: 39918743
PMC: 11806179.
DOI: 10.1186/s13568-025-01829-1.
Characteristics of lower respiratory microbiota in children's refractory pneumonia pre- and post-COVID-19 era.
Xi Z, Chen J, Wang L, Lu A
Front Cell Infect Microbiol. 2025; 14:1438777.
PMID: 39906212
PMC: 11792091.
DOI: 10.3389/fcimb.2024.1438777.
Characteristics of the 2023-2024 epidemic in adults, Southeast France.
Wolski A, Edouard S, Melo B, Lavrard P, Cortaredona S, Punturo J
IJID Reg. 2025; 14:100548.
PMID: 39877414
PMC: 11773249.
DOI: 10.1016/j.ijregi.2024.100548.
Ongoing post-pandemic peak of cases in July 2024: A single-center experience in north-west Italy.
Novazzi F, Arcari G, Perniciaro S, Boutahar S, Niccolini N, Ferrante F
IJID Reg. 2025; 14:100554.
PMID: 39866848
PMC: 11764703.
DOI: 10.1016/j.ijregi.2024.100554.
A diagnostic host-specific transcriptome response for Mycoplasma pneumoniae pneumonia to guide pediatric patient treatment.
Viz-Lasheras S, Gomez-Carballa A, Bello X, Rivero-Calle I, Dacosta A, Kaforou M
Nat Commun. 2025; 16(1):673.
PMID: 39809748
PMC: 11733158.
DOI: 10.1038/s41467-025-55932-9.
.
Paquette M, Magyar M, Renaud C
CMAJ. 2025; 197(1):E26-E27.
PMID: 39805644
PMC: 11684928.
DOI: 10.1503/cmaj.240085-f.
: not a typical respiratory pathogen.
Rowlands R, Meyer Sauteur P, Beeton M, The Escmid Study Group For Mycoplasma And Chlamydia Infections Esgmac
J Med Microbiol. 2024; 73(10).
PMID: 39475213
PMC: 11523975.
DOI: 10.1099/jmm.0.001910.
incidence, phenotype, and severity in children and adolescents in Denmark before, during, and after the COVID-19 pandemic: a nationwide multicentre population-based cohort study.
Dungu K, Holm M, Hartling U, Jensen L, Nielsen A, Schmidt L
Lancet Reg Health Eur. 2024; 47:101103.
PMID: 39469091
PMC: 11513821.
DOI: 10.1016/j.lanepe.2024.101103.
New Insights into the Epidemiological Characteristics of Infection before and after the COVID-19 Pandemic.
Wu Q, Pan X, Han D, Ma Z, Zhang H
Microorganisms. 2024; 12(10).
PMID: 39458327
PMC: 11509874.
DOI: 10.3390/microorganisms12102019.
.
Paquette M, Magyar M, Renaud C
CMAJ. 2024; 196(32):E1120.
PMID: 39353637
PMC: 11444693.
DOI: 10.1503/cmaj.240085.
An outbreak of in children after the COVID-19 pandemic, Shanghai, China, 2023.
Zhu X, Liu P, Yu H, Wang L, Zhong H, Xu M
Front Microbiol. 2024; 15:1427702.
PMID: 39206369
PMC: 11350404.
DOI: 10.3389/fmicb.2024.1427702.
Epidemiological characteristics and early predict model of children Mycoplasma Pneumoniae Pneumonia outbreaks after the COVID-19 in Shandong.
Zeng Q, Li Y, Yue Y, Wang M, Yang C, Lv X
Sci Rep. 2024; 14(1):19892.
PMID: 39192024
PMC: 11350198.
DOI: 10.1038/s41598-024-71010-4.
Increased macrolide resistance rate of correlated with epidemic in Beijing, China in 2023.
Chen Y, Jia X, Gao Y, Ren X, Du B, Zhao H
Front Microbiol. 2024; 15:1449511.
PMID: 39171272
PMC: 11337199.
DOI: 10.3389/fmicb.2024.1449511.
Mycoplasma pneumoniae infection outbreak in Guangzhou, China after COVID-19 pandemic.
Li Y, Wu M, Liang Y, Yang Y, Guo W, Deng Y
Virol J. 2024; 21(1):183.
PMID: 39129001
PMC: 11318190.
DOI: 10.1186/s12985-024-02458-z.
Persistent elevation in incidence of pneumonia in children in England, 2023/24.
Todkill D, Lamagni T, Pebody R, Ramsay M, Woolham D, Demirjian A
Euro Surveill. 2024; 29(32).
PMID: 39119723
PMC: 11312015.
DOI: 10.2807/1560-7917.ES.2024.29.32.2400485.
Macrolide-resistant infection in children observed during a period of high incidence in Henan, China.
Leng M, Yang J, Liu X
Heliyon. 2024; 10(13):e33697.
PMID: 39040303
PMC: 11260988.
DOI: 10.1016/j.heliyon.2024.e33697.